Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma

Tumor biopsies may help to reliably distinguish hepatocellular carcinoma (HCC) from other tumors, mostly cholangiocarcinoma as well as to identify the patient populations who most benefit from target-driven HCC treatments, in order to improve the success rate of experimental therapies. Clarifying tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rimassa, Lorenza, Reig, Maria, Abbadessa, Giovanni, Peck-Radosavljevic, Markus, Harris, William, Zagonel, Vittorina, Pastorelli, Davide, Rota Caremoli, Elena, Porta, Camillo, Damjanov, Nevena, Patel, Hitendra, Daniele, Bruno, Lamar, Maria, Schwartz, Brian, Goldberg, Terri, Santoro, Armando, Bruix, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Letters To The Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385412/
https://www.ncbi.nlm.nih.gov/pubmed/28428725
http://dx.doi.org/10.3748/wjg.v23.i13.2448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385412/
https://www.ncbi.nlm.nih.gov/pubmed/28428725
http://dx.doi.org/10.3748/wjg.v23.i13.2448

Ejemplares similares